SCHEMBL8205348

SCHEMBL8205348

C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)c2ccc(O)cc21

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 4/20 0.79
CYP19A1 P11511 14/20 0.64
STS P08842 3/20 0.64
LMNA P02545 2/20 0.64
ESR1 P03372 2/20 0.64
AKR1B10 O60218 1/20 0.64
SHBG P04278 1/20 0.64
CYP1A2 P05177 1/20 0.64
PGR P06401 1/20 0.64
SERPINA6 P08185 1/20 0.64
CYP3A4 P08684 1/20 0.64
AR P10275 1/20 0.64
MAPT P10636 1/20 0.64
AKR1B1 P15121 1/20 0.64
NFKB1 P19838 1/20 0.64
SLC6A4 P31645 1/20 0.64
OPRM1 P35372 1/20 0.64
SNCA P37840 1/20 0.64
HTR2B P41595 1/20 0.64
BLM P54132 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12593631 1.00 HSD17B1 (0.79) HSD17B1CYP19A1STSLMNAESR1
SCHEMBL1977286 0.88 HSD17B1 (1.00) HSD17B1CYP19A1STSLMNAESR1
SCHEMBL12379610 0.88 HSD17B1 (1.00) HSD17B1CYP19A1STSLMNAESR1
SCHEMBL7643585 0.84 HSD17B1 (0.59) HSD17B1CYP19A1STSLMNAESR1
SCHEMBL7176305 0.82 HSD17B1 (0.80) HSD17B1CYP19A1STSLMNAESR1
SCHEMBL12593499 0.80 HSD17B1 (0.52) HSD17B1CYP19A1STSLMNAESR1
SCHEMBL3964402 0.80 SHBG (0.62) HSD17B1CYP19A1STSLMNAESR1
Hydrochloric Acid SCHEMBL6409710 0.79 SHBG (0.61) HSD17B1CYP19A1STSLMNAESR1
Estrone SCHEMBL23529835 0.79 CYP19A1 (0.95) HSD17B1CYP19A1STSLMNAESR1
Estrone SCHEMBL7831317 0.78 CYP19A1 (1.00) HSD17B1CYP19A1STSLMNAESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6080735-A SUITABLE FOR HORMONAL CONTRACEPTION AND CLIMACTERIC HORMONE REPLACEMENT THERAPY (HRT) AS WELL AS FOR TREATMENT OF GYNECOLOGICAL AND ANDROLOGICAL DISEASES JENAPHARM GMBH & CO. KG (DE) 2000-06-27 US disclosed